Skip to content

OnyxBiotech News

Subscribe About Onyx
Cell & Gene Leaders Live Sunday 15 November 2026 · The Shard (Shangri-La), London · One-day summit for cell & gene therapy leaders Sunday 15 November 2026 · The Shard (Shangri-La), London Get tickets → London Life Sciences Week Guide The unofficial London Life Sciences Week Guide, published by Onyx Newsroom · Every event 15–19 November 2026 Every event 15–19 November 2026 · Published by Onyx Newsroom Plan your week →
Live Interviews Editor's pick

Stephen Majors, Vice President, Global Communications and Investor Relations, Alliance for Regenerative Medicine | Onyx Live | Cell & Gene Meeting on the Med 2026

Over 400 organisations across 25 countries are racing to bring these therapies to patients with otherwise untreatable diseases.

Table of Contents

Three cell and gene therapy products now exceed $1 billion in annual global sales – proof that one-time, potentially curative treatments work at commercial scale.

Over 400 organisations across 25 countries are racing to bring these therapies to patients with otherwise untreatable diseases.

The Alliance for Regenerative Medicine is the leading global advocacy organisation for cell and gene therapies. Its flagship Cell & Gene Meeting on the Med, held at the Rome Cavalieri in April 2026, brought 45+ leading developers together for three days of partnering and commercialisation strategy, while ARM's quarterly Sector Snapshot reports track every clinical readout, financing round and regulatory decision shaping the field.

At Meeting on the Med 2026, reporting for Onyx, Federico Citterich sat down with Stephen Majors to find out more.

A special thanks to our Onyx Live sponsors:

Cellares - delivering cell therapy manufacturing excellence at scale across a global network of IDMO smart factories https://www.cellares.com/

Coming up: Cell & Gene Leaders Live, Sun 15 Nov at The Shard · London Life Sciences Week Guide, 15–19 Nov 2026 ·

Comments